Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (NY:GSK)

48.85 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Dec 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about GSK plc American Depositary Shares (Each representing two Ordinary Shares)

< Previous 1 2 3 4 5 6 7 8 9
...
43 44 Next >
Fitch Sees Stable 2026 Outlook For Global Pharma — But Warns Trump Drug Pricing Push Poses Profit Risk ↗
Via Stocktwits
Topics Government
News headline image
The Pfizer Pivot: A Deep-Dive into PFE’s 2025 Financial Recovery and Strategic Rebirth
As of today, December 22, 2025, Pfizer Inc. (NYSE: PFE) stands as a case study in corporate reinvention and the brutal reality of the post-pandemic "hangover." Once the darling of the global healthcare... 
Via PredictStreet
Topics Economy Intellectual Property
News headline image
Moderna (MRNA): The “Act 2” of an mRNA Pioneer – A 2025 Deep Dive
As of December 22, 2025, Moderna, Inc. (NASDAQ: MRNA) stands at a critical juncture in its corporate evolution. Once the poster child for the biotechnology industry’s rapid response to the global... 
Via PredictStreet
Topics Earnings Initial Public Offering Intellectual Property
ANAB Stock Falls After It Sues GSK Unit Tesaro Again, Claims Fresh Breach Of 2014 Deal ↗
The dispute centers around Tesaro’s participation in PD-1 trials. 
Via Stocktwits
Topics Lawsuit
News headline image
Earnings Scheduled For October 29, 2025 ↗
 
Via Benzinga
GSK Buys Global Rights To Preclinical Cancer Therapy For $357M ↗
Via Stocktwits
News headline image
GSK PLC-SPON ADR (NYSE:GSK) Shows Strong Technical Setup for Potential Breakout ↗
GSK stock shows strong technical strength and a high-quality setup, signaling a potential breakout for trend-focused investors. 
Via Chartmill
News headline image
Trump Strikes New Drug-Price Deals With Roche, Novartis, Merck And Other Pharma Giants ↗
The deals expand the pricing program to most targeted drugmakers in exchange for temporary tariff relief. 
Via Stocktwits
Topics Government World Trade
News headline image
Exdensur (depemokimab) approved by US FDA for the treatment of severe asthma
From GSK plc
Via Business Wire
News headline image
Value Stocks Stage a Comeback Bid Amidst Persistent Growth Dominance
The financial markets in late 2025 present a complex narrative, a tug-of-war between the long-reigning titans of growth and a resurgent, yet often overshadowed, cohort of value stocks. While the... 
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
Great Rotation: Tech Exodus Fuels Dow's Record Run While Nasdaq Struggles
As of December 12, 2025, the financial markets are witnessing a significant "Great Rotation," a pronounced shift of capital from high-growth technology and Artificial Intelligence (AI) stocks to more... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
GSK PLC-SPON ADR (NYSE:GSK) Presents a High-Probability Technical Breakout Setup ↗
GSK stock shows strong technical momentum and a high-quality consolidation pattern, indicating a potential breakout opportunity for traders. 
Via Chartmill
News headline image
Biotech Bull ETF Surges To 20-Month High: Analysts Say Medicare’s Drug-Pricing Blow Is Softer Than Feared ↗
Pricing updates for major therapies from Novo Nordisk, Teva, AbbVie, and others eased sector worries. 
Via Stocktwits
Topics ETFs
News headline image
JPMorgan Says 2027 Medicare Drug Prices Signal Up To 40% Cuts Ahead — Novo Nordisk And Teva Stand Out As Top Targets ↗
JPMorgan said the implied net impact aligns with recent commentary from Novo Nordisk, Teva and AbbVie during earnings season. 
Via Stocktwits
Topics Economy Government
News headline image
The Best Healthcare Stock to Hold in Uncertain Times ↗
Looking for a cheap, safe healthcare stock to buy? Take two shares of GSK and call me in the morning. 
Via The Motley Fool
Topics Economy World Trade
News headline image
AI’s Next Frontier: Key Stocks to Watch Amidst Market Shifts and Technological Leaps
The artificial intelligence (AI) sector is currently navigating a period of unprecedented dynamism, characterized by explosive technological advancements, massive capital inflows, and a palpable... 
Via TokenRing AI
Topics Artificial Intelligence
News headline image
AnaptysBio To Save $10 Million After Discontinuing Ulcerative Colitis Study ↗
AnaptysBio ends its ulcerative colitis trial after rosnilimab misses key goals, focusing resources on rheumatoid arthritis and future programs. 
Via Benzinga
News headline image
Looking Into GSK PLC's Recent Short Interest ↗
 
Via Benzinga
News headline image
FDA Fast-Tracks 6 More Drugs - Obesity And Cancer Drugs Included ↗
FDA adds six drugs to its priority voucher program as CMS and the White House unveil measures to speed reviews and lower prescription costs. 
Via Benzinga
News headline image
AI Revolutionizes Pharma Supply Chains: A New Era of Localized Resilience and Efficiency
The pharmaceutical industry is experiencing a profound and immediate transformation as Artificial Intelligence (AI) becomes a strategic imperative for localizing supply chains, fundamentally enhancing... 
Via TokenRing AI
Topics Artificial Intelligence Economy Fraud
News headline image
The Fading Luster: Is the "Gold Rush Over" While Stocks Remain "Overheated"?
The financial markets are currently grappling with a potent and increasingly vocal narrative: the "gold rush is over" for commodities, particularly gold, while the stock market, especially in certain... 
Via MarketMinute
Topics Artificial Intelligence Cannabis ETFs
News headline image
2 High-Yield Stocks With Fresh Catalysts ↗
Income investors can capture yields above 5% from companies executing business transformations. 
Via The Motley Fool
Topics Lawsuit
News headline image
Navigating the Turbulence: Understanding Market Volatility Amidst Record Highs
As late 2025 unfolds, the global stock market presents a fascinating paradox: major U.S. indices, including the S&P 500, Dow Jones Industrial Average (NYSE: ^DJI), and Nasdaq Composite (NASDAQ: ^IXIC),... 
Via MarketMinute
Topics Artificial Intelligence Bankruptcy Bonds
News headline image
GSK Upgrades 2025 Financial Outlook, CEO Says Positioned Well For 2026 ↗
GSK's Q3 sales and earnings topped estimates, driven by Specialty Medicines and vaccines, prompting the firm to raise its 2025 outlook. 
Via Benzinga
News headline image
GSK Jumps After Hiked 2025 Guidance Widely Outperforms Expectations ↗
GSK stock rose early Wednesday on strong 2025 guidance on the back of its third-quarter sales and earnings beat. 
Via Investor's Business Daily
News headline image
Dow Jones Soars to New Record High Amidst Wave of Optimism, Signaling Robust Market Confidence
The Dow Jones Industrial Average (DJIA) recently achieved a significant milestone, surging by over 200 points to close at an unprecedented all-time record high in October 2025. This remarkable ascent... 
Via MarketMinute
Topics Artificial Intelligence Economy Energy
News headline image
FDA Approves GSK's Withdrawn Blood Cancer Drug Blenrep ↗
FDA approves GSK's Blenrep combo for relapsed multiple myeloma, showing 51% reduced death risk and tripled progression-free survival in Phase 3 trial. 
Via Benzinga
News headline image
GSK Crumbles As Blood Cancer Comeback Falls Unexpectedly Short ↗
The company won approval for its drug, Blenrep. But it wasn't enough. 
Via Investor's Business Daily
News headline image
Blenrep approved by US FDA for use in treatment of relapsed/refractory multiple myeloma
From GSK plc
Via Business Wire
News headline image
Clinical Failure Halts Alector's Dementia Program, Company Reduces Workforce ↗
Alector's Phase 3 trial for FTD-GRN drug, latozinemab, failed the clinical co-primary endpoint. The program is discontinued; Alector cuts 49% of staff. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
43 44 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.